Development of a rapid and fully automated Idylla™ assay for qualitative detection of mutations in the PIK3CA and AKT1 gene in advanced breast cancer FFPE samples. (October 2022) - Piofczyk, T.; Covens, K.; Adriany, T.; Petruskeviciute, M.; Lopez-Jimena, B.; De Vega, D.; Roesl, C.; Kavanagh-Williamson, M.; Wuyts, J.; Forster, T.; Campos, J.; Daems, D.; et al.